Ohsong Pharm was honored with an export award at the 6^소  6th Jeju Export Day ceremony, held on the 14^소 at the Jeju Special Self-Governing Province Office.

Headquartered in Jeju Island, Ohsong Pharm is a leading pharmaceutical company in Korea and a

'Specialty Pharmaceuticals Trading Company'. The company actively collaborates with partner pharmaceutical firms and engages in market research and product concept discussions for the Japan pharmaceutical market.

is the business model is distinguished by its collaborative approach from the very beginning. In 2015, the company took a significant step towards business diversification by becoming the first company in Jeju to acquire a wholesale license for raw pharmaceutical materials.

The company has also demonstrated export performance, winning $10 million and $20 million export achievement awards at the 47th (2010) and 48th (2011) Trade Days, respectively.

Looking ahead, Ohsong Pharm plans to establish Ohsong Pharm Japan (tentative name) in Tokyo in 2017. The company intends  to apply for clinical trials and regulatory approvals in Japan – an achievement considered rare among domestic healthcare companies. Operating a licensed subsidiary with clinical research capabilities will further strengthen its position in the Japanese market.

With this latest export award, Ohsong Pharm reaffirmed its ambition to become a leading exporter of pharmaceuticals to Japan, aiming to connect not only Korea and Japan but also the global market and Japan.